Not applicableStudy completedNCT02548780What this trial is testingLifePearl-Doxo Pharmacokinetic (PK) StudyWho this might be right forHCCHepatocellular Carcinoma Terumo Europe N.V. 15
Testing effectiveness (Phase 2)Looking for participantsNCT06397222What this trial is testingSintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCCWho this might be right forHepatocellular Carcinoma Non-resectable Second Affiliated Hospital of Guangzhou Medical University 23
Not applicableUnknownNCT01891539What this trial is testingObservational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular CarcinomaWho this might be right forLiver Cell Carcinoma Non-resectable International Group of Endovascular Oncology 100
Not applicableUnknownNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 210
Not applicableNot Yet RecruitingNCT07206511What this trial is testingConversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort StudyWho this might be right forUnresectable Hepatocellular Carcinom Shanghai Zhongshan Hospital 278
Testing effectiveness (Phase 2)WithdrawnNCT05327738What this trial is testingYttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular CarcinomaWho this might be right forBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+2 more OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT02967887What this trial is testingEvaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCCWho this might be right forHepatocellular Carcinoma Non-Resectable CbsBioscience 96
Early research (Phase 1)Study completedNCT00467194What this trial is testingSirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryWho this might be right forLiver Cancer National Cancer Centre, Singapore 27
Testing effectiveness (Phase 2)Study completedNCT05003700What this trial is testingHepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Nanfang Hospital, Southern Medical University 39
Not applicableLooking for participantsNCT05713994What this trial is testingCombined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Non-resectable Ze-yang Ding, MD 300
Not applicableUnknownNCT03283956What this trial is testingSafety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in TaiwanWho this might be right forHepatocellular Carcinoma Non-resectableChemoembolization, Therapeutic National Taiwan University Hospital 500
Testing effectiveness (Phase 2)Study completedNCT01010126What this trial is testingTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more National Cancer Institute (NCI) 252
Large-scale testing (Phase 3)UnknownNCT03780049What this trial is testingHAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-BWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 304
Testing effectiveness (Phase 2)UnknownNCT05582278What this trial is testingHAIC+Lenvatinib+Tislelizumab vs D-TACE+Lenvatinib+Tislelizumab for Unresectable HCCWho this might be right forUnresectable Hepatocellular Carcinoma Wen Li 60
Not applicableLooking for participantsNCT06365034What this trial is testingStudy on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular CarcinomaWho this might be right forCarcinoma, Hepatocellular Qianfoshan Hospital 92
Testing effectiveness (Phase 2)Looking for participantsNCT07227012What this trial is testingLearn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.Who this might be right forCarcinoma, HepatocellularHepatocellular CancerHepatocellular Carcinoma+4 more Pfizer 138
Testing effectiveness (Phase 2)Ended earlyNCT05630937What this trial is testingStudy on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic TherapyWho this might be right forUnresectable Hepatocellular Carcinoma (HCC) Nerviano Medical Sciences 31
Early research (Phase 1)UnknownNCT04592029What this trial is testingTACE Combined With Sintilimab and Bevacizumab for Unresectable HCCWho this might be right forHepatocellular Carcinoma Non-resectable Second Affiliated Hospital of Guangzhou Medical University 36
Not applicableLooking for participantsNCT06117891What this trial is testingAn Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With SurgeryWho this might be right forUnresectable Hepatocellular Carcinoma Bayer 300
Early research (Phase 1)Study completedNCT01042041What this trial is testingSorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver CancerWho this might be right forHepatocellular CarcinomaLiver CancerLocalized Unresectable Liver Cancer Abramson Cancer Center at Penn Medicine 18